p53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas

Journal of Medical and Dental Sciences

Volumn 48, Issue 4, 2001, Pages 113-119

  Shwe, Myint ^a,b,c   Chiguchi, Gaku ^a   Yamada, Shumpei ^a   Nakajima, Takuma ^a   Maung, Ko Ko ^b,c   Takagi, Minoru ^a   Amagasa, Teruo ^a   Tsuchida, Nobuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Institute of Dental Medicine   (Myanmar)

^c NONE   (Myanmar)

Author keywords

MDM2; Oral squamous cell carcinoma; p53; Tobacco betel chewing

Indexed keywords

CARCINOGEN; MDM2 PROTEIN, HUMAN; MUTAGENIC AGENT; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53; TUMOR PROTEIN;

ARTICLE; BETEL NUT; CHI SQUARE DISTRIBUTION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; MOUTH TUMOR; MUTATION; ONCOGENE; PHENOTYPE; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICS; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ARECA; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; MUTAGENS; MUTATION; MUTATION, MISSENSE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ONCOGENES; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SMOKING; STATISTICS; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035553190     PISSN: 13428810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Daftary DK, Murti PR, Bhonsle RR, et al. Risk factors and risk marker for oral cancer in high risk areas of the world. Oral Cancer. Edited by NW Johnson. Cambridge: Cambridge University Press, 1991: 29-63
2. Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med 1993; 328: 184-94
3. Thomas S, Brennan J, Martel G, et al. Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua-New Guinea. Cancer Res. 1994; 54: 3588-93
4. Kannan K, Munirajan AK, Krishnamurthy J, et al. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India. Int J Oncol 1999; 15: 1133-6
5. Cahilly-Snyder L, Yang-Feng P, Francke U, et al. Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet 1987; 13: 235-44
6. Momand J, Zambetti GP, Olson DC, et al. The MDM2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 1992; 69: 1237-45
7. Wu X, Bayle JH, Olson D, et al. The p53-MDM2 autoregulatory feedback loop. Genes Dev 1993; 7: 1126-32
8. Chen CY, Oliner JD, Zhan Q, et al. Interactions between p53 and MDM2 in a mamalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA 1994; 91: 2684-8
9. Haupt Y, Maya R, Kazaz A, et al. MDM2 promotes the rapid degradation of p53. Nature 1997; 387: 296-9
10. Sarkar FH, Valdivieso M, Borders J, et al. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue. Diag Mol Pathol 1995; 4: 266-73
11. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994; 54: 4855-4878
12. Sakai E, Rikimaru K, Ueda M, et al. The p53 tumor suppressor gene and ras oncogene mutations in oral squamous cell carcinoma. Int J Cancer 1992; 52: 867-72
13. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor suppressor gene. Oncogene 1992; 7: 927-33
14. Orita M, Iwhara H, Kanazawa H, et al. Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-70
15. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981; 75: 816-21
16. Nylander K, Schildt EB, Eriksson M, et al. A non-random detection in the p53 gene in oral squamous cell carcinoma. Br J Cancer 1996; 73: 1381-6
17. Portugal LG, Goldenberg JD, Wenig BL, et al. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1997; 123: 1230-4
18. Munirajan AK, Tutsu-Ishii Y, Mohanprasad BKC, et al. p53 gene mutations in oral carcinomas from India. Int J Cancer 1996; 66: 297-300
19. Wong YK, Liu TY, Chang KW, et al. p53 alterations in betel quid and tobacco-associated oral squamous cell carcinomas from Taiwan. J Oral Pathol Med 1998; 27: 243-8
20. Heinzel PA, Balarana P, Bernard HU. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Int J Cancer 1996; 68: 420-3
21. Saranath D, Tandle AT, Teni TR, et al. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Eur J Cancer B, Oral Oncology 1999; 35: 242-50
22. Kuo MYP, Huang JS, Hsu HC, et al. Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999; 28: 221-5
23. Agarwal S, Mathur M, Srivastava A, et al. MDM2/p53 co-expression in oral premalignant and maliignant lesions: potential prognostic implications. Eur J Cancer B, Oral Oncol 1999; 35: 209-16
24. Huang JS, Ho TJ, Chiang CP, et al. MDM2 expression in areca quid chewing-associated oral squamous cell carcinomas in Taiwan. J. Oral Pathol Med 2001; 30: 53-8
25. Gelsleichter L, Gown AW, Zarro RJ, et al. p53 and MDM2 expression in malignant melanoma: an immunocytochemical study of expression of p53, MDM2, and markers of cell proliferation in primary versus metastatic tumors. Mod Pathol 1995; 8: 530-5
26. Lianes P, Orlow I, Zhang ZF, et al. Altered patterns of MDM2 and p53 expression in human bladder cancer. J Nat Cancer Inst 1994; 86: 1325-30
27. Gorgoulis VG, Zoumpourlis V, Rassidakis GZ, et al. A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinomas. J Pathol 1996; 180: 129-37
28. Li XJ, Murai M, Koyama T, et al. MDM2 overexpression with alteration of the p53 protein and gene status in oral carcinogenesis. Jpn J Cancer Res 2000; 91: 492-8
29. Esteller M, Cordon-Cardo C, Com PG, et al. p14ARF silencing by promoter hypermethtlation mediates abnormal intracellular localization of MDM2. Cancer Res 2001; 61: 2816-21
30. Oliner JD, Kinzler KW, Meltzer PS, et al. Amplification of gene encoding a p53-associated protein in human sarcomas. Nature 1992; 3: 358-80
31. Reifenberger G, Liu L, Ichimura K, et al. Amplification and overexpression of the MDM2 gene in a subset of human malignat gliomas without p53 gene mutations. Cancer Res 1993; 53: 2736-9
32. Leach FS, Tokino T, Meltzer PS, et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 1993; 53: 2231-4